Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 399

The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.

Combined oral contraceptives: venous thrombosis

Open access
de Bastos, Marcos, Stegeman, Bernardine H., Rosendaal, Frits R., Van Hylckama Vlieg, Astrid, Helmerhorst, Frans M, Stijnen, Theo, Dekkers, Olaf M·2014·Cochrane Database of Systematic Reviews

Abstract

BACKGROUND: Combined oral contraceptive (COC) use has been associated with venous thrombosis (VT) (i.e., deep venous thrombosis and pulmonary embolism). The VT risk has been evaluated for many estrogen doses and progestagen types contained in COC but no comprehensive comparison involving commonly used COC is available. OBJECTIVES: To provide a comprehensive overview of the risk of venous thrombosis in women using different combined oral contraceptives. SEARCH METHODS: Electronic databases (Pubmed, Embase, Web of Science, Cochrane, CINAHL, Academic Search Premier and ScienceDirect) were searched in 22 April 2013 for eligible studies, without language restrictions. SELECTION CRITERIA: We selected studies including healthy women taking COC with VT as outcome. DATA COLLECTION AND ANALYSIS: The primary outcome of interest was a fatal or non-fatal first event of venous thrombosis with the main focus on deep venous thrombosis or pulmonary embolism. Publications with at least 10 events in total were eligible. The network meta-analysis was performed using an extension of frequentist random effects models for mixed multiple treatment comparisons. Unadjusted relative risks with 95% confidence intervals were reported.Two independent reviewers extracted data from selected studies. MAIN RESULTS: 3110 publications were retrieved through a search strategy; 25 publications reporting on 26 studies were included. Incidence of venous thrombosis in non-users from two included cohorts was 0.19 and 0.37 per 1 000 person years, in line with previously reported incidences of 0,16 per 1 000 person years. Use of combined oral contraceptives increased the risk of venous thrombosis compared with non-use (relative risk 3.5, 95% confidence interval 2.9 to 4.3). The relative risk of venous thrombosis for combined oral contraceptives with 30-35 μg ethinylestradiol and gestodene, desogestrel, cyproterone acetate, or drospirenone were similar and about 50-80% higher than for combined oral contraceptives with levonorgestrel. A dose related effect of ethinylestradiol was observed for gestodene, desogestrel, and levonorgestrel, with higher doses being associated with higher thrombosis risk. AUTHORS' CONCLUSIONS: All combined oral contraceptives investigated in this analysis were associated with an increased risk of venous thrombosis. The effect size depended both on the progestogen used and the dose of ethinylestradiol. Risk of venous thrombosis for combined oral contraceptives with 30-35 μg ethinylestradiol and gestodene, desogestrel, cyproterone acetate and drospirenone were similar, and about 50-80% higher than with levonorgestrel. The combined oral contraceptive with the lowest possible dose of ethinylestradiol and good compliance should be prescribed-that is, 30 μg ethinylestradiol with levonorgestrel.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd010813.pub2

Cites

133 of 133 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 133 references

Research works printed but not linked: 31

  1. Farmer, 1996, Safety of modern oral contraceptives, Lancet, 347, 259
  2. Samuelsson, 2004, Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users, Acta Obstet Gynecol Scand, 83, 674, 10.1111/j.0001-6349.2004.00574.x · doi:10.1111/j.0001-6349.2004.00574.x
  3. Amundsen, 2000, Tidsskr, Nor Laegeforen, 120, 326
  4. Austin, 2009, Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women, Am J Obstet Gynecol, 200, 620. e1-620.e3, 10.1016/j.ajog.2009.01.038 · doi:10.1016/j.ajog.2009.01.038
  5. Barsoum, 2010, A population-based case-control study, Thrombosis Research, 126, 373-8
  6. Bernstein, 1986, Pulmonary Embolism in Adolescents, AJDC, 140, 667
  7. Bonifacj, 1997, Case control studies of the risk factors for deep-vein thrombosis in an adult population hospitalized in internal medicine, Rev Epidemiol Sante Publique, 45, 465
  8. Burnhill, 1999, Int J Fertil, Womens Med, 44, 19
  9. Diddle, 1978, Oral contraceptives steroids and thrombophlebitis, J Tenn Med Assoc, 71, 22-26
  10. Fuertes, 1971, Thrombophlebitis among oral contraceptives for contraception, Obstet Gynecol, 38, 259
  11. Heuser, 2004, Specific oral contraceptive use and venous thromboembolism resulting in hospital admission, N Z M J, 117, U1176
  12. Anonymous, 1976, IPPF, Med Bull, 10, 2
  13. Kieler, 2003, Thromboembolism and combined oral contraceptives. Spontaneous reporting of adverse drug reactions indicate at least similar risk with themost recent contraceptives, Läkartidningen, 100, 3050
  14. Lambrekht, 1986, [Hormonal contraceptive agents as a risk factor in the development of acute thromboembolic diseases], Khirurgiia (Mosk), 12, 90
  15. Lawrenson, 2000, Venous thromboembolism and combined oral contraceptives: does the type of progestogen make a difference?, Contraception, 62, 21S-28S, 10.1016/S0010-7824(00)00147-5 · doi:10.1016/s0010-7824(00)00147-5
  16. Lewis, 1997, The role of bias in observational studies, Contraception, 55, 189
  17. Lis, 1993, A concurrent cohort study of oral contraceptive use and cardiovascular risks, Pharmacoepidemiol Drug Saf, 2, 51, 10.1002/pds.2630020107 · doi:10.1002/pds.2630020107
  18. Ludwig, 1970, Ovulationshemmer und Venenerkrankungen, Ergebnisse der Angiologie und Phlebologie, 4, 81-102
  19. Meurer, 2001, What is the risk of venous thromboembolism (VT) among women taking third generation oral contraceptives ((COCs) in comparison with those taking contraceptives containing levonorgestrel?, The Journal of Family Practice, 50, 108
  20. Overgaard, 1986, [Venous thromboembolic disease and oral contraceptives], Ugeskr Laeger, 148, 2348
  21. Poulter, 1996, Safety of combined oral contraceptive pills (letter), Lancet, 347, 547
  22. Reed, 2012, VTE risk in users of combined oral contraceptives: Impact of a 24-day regimen containing drospirenone, Pharmacoepidemiology and Drug Safety, Conference, 169
  23. Seigel, 1969, Oral contraceptives and relative risk of death from venous and pulmonary thromboembolism in the United States, American Journal of Epidemiology, 90, 11, 10.1093/oxfordjournals.aje.a121045 · doi:10.1093/oxfordjournals.aje.a121045
  24. Tosetto, 2003, Prevalence and risk factors of venoud non-fatal venous thromboembolism in the active population of the VITA project, J Thromb Haermost, 1, 1724, 10.1046/j.1538-7836.2003.00313.x · doi:10.1046/j.1538-7836.2003.00313.x
  25. Tsankova, Ginekol, 2010, 49, 8
  26. Vallee, [Risk of venous thromboembolism among users of third-generation oral contraceptives], Presse Med, 30, 535
  27. Worralurt, 2005, Risk factors of venous thromboembolism (VT) in Thai reproductive aged female: King Chulalongkorn Memorial Hospital experience, J Med Assoc Thai, 88, 1502
  28. Henzl, 2000, Pharmacology of progestins: 17 alpha-hydroxyprogesterone derivatives and progestins of the first and second generation, 101
  29. Kuhl, 1998, Dienogest, Drugs, 56, 834, 10.2165/00003495-199856050-00008 · doi:10.2165/00003495-199856050-00008
  30. Qaseem, 2007, The Joint American Academy of Family Physicians/American College of Physicians Panel on deep venous thrombosis/pulmonary embolism. Practice guideline from the American Academy of Family Physicians and the American College of Physicians, Annals of Family Medicine, 5, 57, 10.1370/afm.667 · doi:10.1370/afm.667
  31. Wharton, 1988, Lower dose pills, Population Reports, 16, 1

Cited by

See all 399

Metadata

Authors
de Bastos, M., Stegeman, B. H., Rosendaal, F. R., Van Hylckama Vlieg, A., Helmerhorst, F. M., Stijnen, T., & Dekkers, O. M.
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2014-03-03
Volume
2014
Issue
3
Pages
CD010813-CD010813
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W1574745824
Cited by
399
References
133
FWCI
19.15
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Combined oral contraceptives: venous thrombosis. https://app.cochat.ai/papers/10.1002/14651858.cd010813.pub2
The paper
de Bastos, M., Stegeman, B. H., Rosendaal, F. R., Van Hylckama Vlieg, A., Helmerhorst, F. M., Stijnen, T., & Dekkers, O. M. (2014). Combined oral contraceptives: venous thrombosis. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd010813.pub2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.